503B Outsourcing Facility One, LLC
FDA 503B outsourcing facility
West Palm Beach, Florida
Key Takeaways
- FDA-registered 503B outsourcing facility since 2025
- Sterile compounding from bulk substances: Yes
- Not yet inspected by the FDA
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- February 18, 2025
- Most recent registration
- January 27, 2026
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- Not yet inspected
503B Outsourcing Facility One, LLC has registered with the FDA as a 503B outsourcing facility but has not yet been inspected. The FDA inspects registered facilities on a risk-based schedule once drug production and distribution are confirmed.
Compounded peptides and GLP-1s
503B Outsourcing Facility One, LLC has not assigned NDCs or filed product reports in the most recent FDA reporting periods. 503B outsourcing facilities are a primary supply route for compounded peptides and GLP-1s during FDA-listed shortages; PeptideGrids grades the evidence for each, including Semaglutide, Tirzepatide, BPC-157, Retatrutide. Browse the GLP-1 and therapeutic peptide databases.
Contact
FDA-registered contact: Kenneth Metzler, 1-754-265-4280. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of 503B Outsourcing Facility One, LLC with the Florida Board of Pharmacy.
503B facilities in Florida
Florida has 16 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in Florida.
Frequently asked questions
Is 503B Outsourcing Facility One, LLC registered with the FDA?
Yes. 503B Outsourcing Facility One, LLC is a registered 503B outsourcing facility, first registered with the FDA on February 18, 2025 and most recently registered on January 27, 2026.
Has 503B Outsourcing Facility One, LLC been inspected by the FDA?
503B Outsourcing Facility One, LLC has registered with the FDA but has not yet been inspected as a 503B outsourcing facility.
Has 503B Outsourcing Facility One, LLC had any FDA drug recalls?
No FDA drug recalls are matched to 503B Outsourcing Facility One, LLC in the openFDA enforcement database.
What does 503B Outsourcing Facility One, LLC compound?
503B Outsourcing Facility One, LLC has not filed product reports with NDC-assigned drugs in the most recent FDA reporting periods.
Where is 503B Outsourcing Facility One, LLC located?
503B Outsourcing Facility One, LLC is located in West Palm Beach, Florida.
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by 503B Outsourcing Facility One, LLC. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.